Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesenchymal stem cells avoid allogeneic rejection.

Jennifer M Ryan1, Frank P Barry, J Mary Murphy

  • 1Institute of Immunology, National University of Ireland, Maynooth, Co. Kildare, Ireland. JENNIFER.M.RYAN@nuim.ie

Journal of Inflammation (London, England)
|July 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transition to adulthood: Perspectives from young people with cerebral palsy, parents, and health professionals.

Developmental medicine and child neurology·2026
Same author

Musculoskeletal health among adults with cerebral palsy: A systematic review.

Developmental medicine and child neurology·2026
Same author

The child opportunity index and its association with resting and exercising blood pressure in children: a Chicago metro area pilot study.

Preventive medicine reports·2026
Same author

The prevalence of mental health difficulties and mental disorders among children with cerebral palsy.

BMC psychiatry·2026
Same author

Development and implementation of a child-specific dynamic stretching exercise programme for ambulant children with spastic cerebral palsy: The SPELL trial.

Physiotherapy·2026
Same author

Mental health difficulties in cerebral palsy: A qualitative study of young people's and parents' perspectives.

Developmental medicine and child neurology·2026
Same journal

Administration of human macrophage colony-stimulating factor-mFc fusion protein increases macrophage phagocytic capacity and stimulates liver regeneration in mice.

Journal of inflammation (London, England)·2026
Same journal

Editorial Expression of Concern: The occurrence and development of radiation-induced lung injury after interstitial brachytherapy and stereotactic radiotherapy in SD rats.

Journal of inflammation (London, England)·2026
Same journal

FOXD2-AS1/miR-185-5p/CDC42 axis in chronic obstructive pulmonary disease: clinical significance and mechanistic insights.

Journal of inflammation (London, England)·2026
Same journal

A spotlight on the inflammatory role of uremic toxins in the dysbiosis-CKD axis: a review.

Journal of inflammation (London, England)·2026
Same journal

Myeloperoxidase regulates hypoxia-induced inflammation and oxidative stress in liver-spleen axis.

Journal of inflammation (London, England)·2026
Same journal

Resolvin D1 attenuates senescence-associated secretory phenotype independently of TGF-β-driven cardiac fibroblasts differentiation to myofibroblast.

Journal of inflammation (London, England)·2026
See all related articles

Mesenchymal stem cells (MSCs) avoid immune rejection, enabling regenerative medicine. These cells possess potent mechanisms to evade immune responses, offering therapeutic potential for tissue repair.

Area of Science:

  • Immunology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Adult bone marrow derived mesenchymal stem cells (MSCs) hold promise for regenerative medicine.
  • Replacing damaged tissues like cartilage, bone, and muscle is a key goal.
  • Allogeneic tissue rejection typically hinders such treatments.

Purpose of the Study:

  • To investigate the mechanisms by which MSCs evade allogeneic rejection.
  • To explore the potential of MSCs in regenerative medicine despite immune barriers.

Main Methods:

  • In vitro co-culture studies.
  • Analysis of MSC immunophenotype (MHC-II, costimulatory molecules).
  • Assessment of MSC effects on immune cells (T cells, NK cells, dendritic cells).

Related Experiment Videos

Main Results:

  • MSCs are hypoimmunogenic, often lacking MHC-II and costimulatory molecules.
  • MSCs modulate dendritic cells and directly inhibit T and NK cell function.
  • MSCs create a suppressive microenvironment via prostaglandins, IL-10, and IDO, depleting tryptophan.

Conclusions:

  • MSCs possess multiple mechanisms to avoid allogeneic rejection.
  • These immune-evasive properties support their use in regenerative medicine.
  • MSC-mediated immune tolerance offers a new frontier in treating tissue damage.